Neogenomics (NEO) Cash from Operations Growth (3y) (2013 - 2026)
Neogenomics (NEO) Cash from Operations Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 17.81% |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | -12.11% |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 13.13% |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 35.64% |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | -11.38% |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 14.01% |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 206.88% |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | -3.02% |
| 10 | Neogenomics | 1.93 Bn | 1.79 Bn | 80.86 Mn | 13.77% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.77% |
| Dec 31, 2025 | 33.22% |
| Sep 30, 2025 | 36.55% |
| Jun 30, 2025 | 47.30% |
| Mar 31, 2025 | 4.46% |
| Dec 31, 2024 | 35.64% |
| Sep 30, 2024 | 47.21% |
| Jun 30, 2024 | 128.91% |
| Mar 31, 2024 | -139.43% |
| Dec 31, 2023 | 43.77% |
| Sep 30, 2023 | -131.77% |
| Jun 30, 2023 | -41.32% |
| Mar 31, 2023 | -22.33% |
| Dec 31, 2022 | -45.76% |
| Sep 30, 2022 | -42.16% |
| Jun 30, 2022 | -53.26% |
| Mar 31, 2022 | -89.11% |
| Dec 31, 2021 | -48.58% |
| Sep 30, 2021 | -43.04% |
| Jun 30, 2021 | -30.24% |